Antonio-Arques Violeta, Franch-Nadal Josep, Caylà Joan A
Institut Universitari per a la Recerca en Atenció Primària (IDIAP) Jordi Gol, Barcelona, Spain.
Equip d'Atenció Primària (EAP) Bordeta Magòria, Institut Català de la Salut, Barcelona, Spain.
Med Clin (Engl Ed). 2021 Sep 24;157(6):288-293. doi: 10.1016/j.medcle.2021.04.006. Epub 2021 Sep 11.
Tuberculosis (TB) is the leading cause of infectious mortality in the world, affecting mainly developing countries (DC), while diabetes (DM) is one of the most prevalent chronic diseases. This review analyzes the fact that diabetes is currently an important risk factor for developing TB, also presenting more complicated TB, more relapses and higher mortality. The DCs and the fourth world of the large cities are those with the highest incidence of TB and an increase in DM, which will make it difficult to control tuberculosis disease. At the same time, the COVID-19 pandemic is complicating the management of both diseases due to the difficulty of access to control and treatment and the worsening of socioeconomic inequalities. It is necessary to establish a bidirectional screening for TB and DM and promote recommendations for the joint management of both diseases.
结核病（TB）是全球感染性死亡的主要原因，主要影响发展中国家（DC），而糖尿病（DM）是最常见的慢性病之一。本综述分析了糖尿病目前是结核病发病的重要危险因素，同时还表现出更复杂的结核病、更多的复发和更高的死亡率。发展中国家和大城市的第四世界是结核病发病率最高且糖尿病发病率上升的地区，这将使结核病的控制变得困难。同时，由于难以获得控制和治疗以及社会经济不平等的加剧，新冠疫情使这两种疾病的管理变得更加复杂。有必要建立结核病和糖尿病的双向筛查，并推广两种疾病联合管理的建议。
